Organic anion transporting polypeptide 2 transports valproic acid in rat brain microvascular endothelial cells

References

• Gu L, Liang B, Chen Q, Long J, Xie J, Wu G, et al. Prevalence of epilepsy in the People’s Republic of China: a systematic review. Epilepsy Res. 2013;105(1–2):195–205.10.1016/j.eplepsyres.2013.02.002
   PubMed Web of Science ®Google Scholar
• Sinha S, Siddiqui KA. Definition of intractable epilepsy. Neurosciences. 2011;16(1):3–9.
   Web of Science ®Google Scholar
• Kwan P, Brodie MJ. Potential role of drug transporters in the pathogenesis of medically intractable epilepsy. Epilepsia. 2005;46(2):224–35.10.1111/epi.2005.46.issue-2
   PubMed Web of Science ®Google Scholar
• Löscher W. Drug transporters in the epileptic brain. Epilepsia. 2007;48(Suppl 1):8–13.10.1111/epi.2007.48.issue-s1
   PubMed Web of Science ®Google Scholar
• Potschka H, Luna-Munguia H. CNS transporters and drug delivery in epilepsy. Curr Pharm Des. 2014;20(10):1534–42.10.2174/13816128113199990461
   PubMed Web of Science ®Google Scholar
• Tsuji A. Biopharmaceutical studies on molecular mechanisms of membrane transport. Yakugaku Zasshi. 2002;122(12):1037–58.10.1248/yakushi.122.1037
   PubMed Web of Science ®Google Scholar
• Zolk O, Fromm MF. Transporter-mediated drug uptake and efflux: important determinants of adverse drug reactions. Clin Pharmacol Ther. 2011;89(6):798–805.10.1038/clpt.2010.354
   PubMed Web of Science ®Google Scholar
• Löscher W, Luna-Tortós C, Römermann K, Fedrowitz M. Do ATP-binding cassette transporters cause pharmacoresistance in epilepsy? Problems and approaches in determining which antiepileptic drugs are affected. Curr Pharm Des. 2011;17(26):2808–28.10.2174/138161211797440212
   PubMed Web of Science ®Google Scholar
• Aronica E1, Sisodiya SM, Gorter JA. Cerebral expression of drug transporters in epilepsy. Adv Drug Delivery Rev. 2012;64(10):919–29.10.1016/j.addr.2011.11.008
   PubMed Web of Science ®Google Scholar
• Stępień KM, Tomaszewski M, Tomaszewska J, Czuczwar SJ. The multidrug transporter P-glycoprotein in pharmacoresistance to antiepileptic drugs. Pharmacol Rep. 2012;64(5):1011–9.
   PubMed Web of Science ®Google Scholar
• Zhang C, Kwan P, Zuo Z, Baum L. The transport of antiepileptic drugs by P-glycoprotein. Adv Drug Delivery Rev. 2012;64(10):930–42.10.1016/j.addr.2011.12.003
   PubMed Web of Science ®Google Scholar
• Ueno M, Nakagawa T, Wu B, Onodera M, Huang CL, Kusaka T, et al. Transporters in the brain endothelial barrier. Curr Med Chem. 2010;17(12):1125–38.10.2174/092986710790827816
   PubMed Web of Science ®Google Scholar
• Mikkaichi T, Suzuki T, Tanemoto M, Ito S, Abe T. The organic anion transporter (OATP) family. Drug Metab Pharmacokinet. 2004;19(3):171–9.10.2133/dmpk.19.171
   PubMedGoogle Scholar
• Hagenbuch B, Stieger B. The SLCO (former SLC21) superfamily of transporters. Mol Aspects Med. 2013;34(2–3):396–412.10.1016/j.mam.2012.10.009
   PubMed Web of Science ®Google Scholar
• Svoboda M, Riha J, Wlcek K, Jaeger W, Thalhammer T. Organic anion transporting polypeptides (OATPs): regulation of expression and function. Curr Drug Metab. 2011;12(2):139–53.10.2174/138920011795016863
   PubMed Web of Science ®Google Scholar
• Sprowl JA, Sparreboom A. Uptake carriers and oncology drug safety. Drug Metab Dispos. 2014;42(4):611–22.10.1124/dmd.113.055806
   PubMed Web of Science ®Google Scholar
• Gao B, Stieger B, Noé B, Fritschy JM, Meier PJ. Localization of the organic anion transporting polypeptide 2 (Oatp2) in capillary endothelium and choroid plexus epithelium of rat brain. J Histochem Cytochem. 1999;47(10):1255–63.10.1177/002215549904701005
   PubMed Web of Science ®Google Scholar
• Kim RB. Organic anion-transporting polypeptide (OATP) transporter family and drug disposition. Eur J Clin Invest. 2003;33(s2):1–5.10.1046/j.1365-2362.33.s2.5.x
   PubMed Web of Science ®Google Scholar
• Guo Y, Jiang L. Drug transporters are altered in brain, liver and kidney of rats with chronic epilepsy induced by lithium-pilocarpine. Neurol Res. 2010;32(1):106–12.10.1179/174313209X408954
   PubMed Web of Science ®Google Scholar
• Guo Y, Jiang L, Liu G-X, Chen H-S. Cultivation of rat brain microvascular endothelial cells and the expression of drug transporters in primary BMECs. Chin J Cell Biol. 2007;29(4):560–3.
   Google Scholar
• Guo Y, Jiang L. Effect of anti-epileptic drugs affect on expression of oatp2 in brain and liver of spontaneous epileptic rats. Journal of the Fourth Military Medical University. 2007;28(22):2057–9.
   Google Scholar
• Barot M, Gokulgandhi MR, Agrahari V, Pal D, Mitra AK. Monocarboxylate transporter mediated uptake of moxifloxacin on human retinal pigmented epithelium cells. J Pharm Pharmacol. 2014;66(4):574–83.10.1111/jphp.12139
   PubMed Web of Science ®Google Scholar
• Frey HH, Löscher W. Distribution of valproate across the interface between blood and cerebrospinal fluid. Neuropharmacology. 1978;17(8):637–42.10.1016/0028-3908(78)90160-0
   PubMed Web of Science ®Google Scholar
• Vijay N, Morris ME. Role of monocarboxylate transporters in drug delivery to the brain. Curr Pharm Des. 2014;20(10):1487–98.10.2174/13816128113199990462
   PubMed Web of Science ®Google Scholar
• Guo GL, Staudinger J, Ogura K, Klaassen CD. Induction of rat organic anion transporting polypeptide 2 by pregnenolone-16alpha -carbonitrile is via interaction with pregnane x receptor. Mol Pharmacol. 2002;61(4):832–9.10.1124/mol.61.4.832
   PubMed Web of Science ®Google Scholar
• Chen QX, Hu HH, Zhou Q, Yu AM, Zeng S. An overview of ABC and SLC drug transporter gene regulation. Curr Drug Metab. 2013;14(2):253–64.
   PubMed Web of Science ®Google Scholar
• Luna-Tortós C1, Fedrowitz M, Löscher W. Several major antiepileptic drugs are substrates for human P-glycoprotein. Neuropharmacology. 2008;55(8):1364–75.10.1016/j.neuropharm.2008.08.032
   PubMed Web of Science ®Google Scholar
• Merezhinskaya N, Fishbein WN. Monocarboxylate transporters: past, present, and future. Histol Histopathol. 2009;24(2):243–64.
   PubMed Web of Science ®Google Scholar
• Pierre K, Pellerin L. Monocarboxylate transporters in the central nervous system: distribution, regulation and function. J Neurochem. 2005;94(1):1–14.10.1111/jnc.2005.94.issue-1
   PubMed Web of Science ®Google Scholar
• Maeda T, Hirayama M, Higashi R, Sato M, Tamai I. Characterization of human OATP2B1 (SLCO2B1) gene promoter regulation. Pharm Res. 2006;23(3):513–20.10.1007/s11095-006-9572-6
   PubMed Web of Science ®Google Scholar
• Pardridge WM. Drug transport across the blood-brain barrier. J Cereb Blood Flow Metab. 2012;32(11):1959–72.10.1038/jcbfm.2012.126
   PubMed Web of Science ®Google Scholar
• Follett PL, Vora N, Cross JH. Paediatric intractable epilepsy syndromes: changing concepts in diagnosis and management. Adv Tech Stand Neurosurg. 2012;39:45–60.
   PubMedGoogle Scholar